Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Faces “Daunting” Mission As It Partners With Doctors For Safe Rx Use

Executive Summary

One of FDA's mantras has been that is does not regulate the practice of medicine, and while the agency remains committed to that doctrine, it is now trying to find ways to better influence how doctors prescribe and discuss drugs through its "Safe Use" initiative
Advertisement

Related Content

Advisory Committee Discussions Will Be Key Tool In Developing REMS
“Safe Use” to launch in January
Electronic “Dear Doctor” Network Signs Up 40,000 Physicians
FDA’s Drug Safety Newsletter Exemplifies Communication Challenge
You Must Remember This: FDA Hopes Q&A Format For Recalls Will Help Public
Safety First: FDA Unveils New Postmarketing Management Process For Safety
Safety First: FDA Unveils New Postmarketing Management Process For Safety
Limits Of Risk Management Practices Shown In Renewed Duragesic Warnings
FDA’s “Drug Safety Newsletter” Offers Doctors Quarterly Updates On Risks
Impact of Antidepressant Black Box Juggled By Advisory Committee, FDA
Advertisement
UsernamePublicRestriction

Register

PS049359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel